These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19913827)

  • 1. Perioperative intravesical therapy after transurethral resection for bladder cancer.
    Kamat AM; Lotan YR
    J Urol; 2010 Jan; 183(1):19-20. PubMed ID: 19913827
    [No Abstract]   [Full Text] [Related]  

  • 2. Study launch: transurethral REsection and Single instillation intra-vesical chemotherapy Evaluation in bladder Cancer Treatment (RESECT).
    Gallagher KM; Bhatt NR; Clement K; Kulkarni M; Khadhouri S; Chan L; Jayaraajan K; Matthews M; Shah T; Kasivisvanathan V
    BJU Int; 2020 Aug; 126(2):310-311. PubMed ID: 32776454
    [No Abstract]   [Full Text] [Related]  

  • 3. Transurethral resection and intravesical therapy of superficial bladder tumors.
    Herr HW
    Urol Clin North Am; 1991 Aug; 18(3):525-8. PubMed ID: 1877115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side effects of perioperative intravesical treatment and treatment strategies for these side effects.
    Griffin JG; Holzbeierlein J
    Urol Clin North Am; 2013 May; 40(2):197-210. PubMed ID: 23540778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
    Colombo R
    Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical therapy.
    Herr HW
    Hematol Oncol Clin North Am; 1992 Feb; 6(1):117-27. PubMed ID: 1556045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of non invasive bladder cancers. T1Ga urothelial cell carcinoma: benefit of immediate post operative instillation?].
    Rouprêt M; Guillotreau J; Irani J; Zerbib M
    Prog Urol; 2010 Mar; 20 Suppl 1():S46-9. PubMed ID: 20493444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoprevention in superficial bladder cancer 1988].
    Rübben H
    Urologe A; 1988 May; 27(3):152-7. PubMed ID: 3043877
    [No Abstract]   [Full Text] [Related]  

  • 9. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP
    Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of superficial bladder cancer: what is new?
    Malmström PU
    Curr Opin Urol; 2000 Sep; 10(5):447-51. PubMed ID: 11005450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
    Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
    J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of intravesical chemotherapy and possibilities for improving its efficacy.
    Sylvester RJ
    Eur Urol; 2006 Aug; 50(2):233. PubMed ID: 18219714
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge.
    Washburn DJ
    Clin J Oncol Nurs; 2007 Aug; 11(4):553-9. PubMed ID: 17723968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underutilization of immediate intravesical chemotherapy following TURBT: results from NSQIP.
    Kowalik C; Gee JR; Sorcini A; Moinzadeh A; Canes D
    Can J Urol; 2014 Jun; 21(3):7266-70. PubMed ID: 24978355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative instillation therapy in superficial bladder cancer: is it effective regarding outcome and costs?
    Engel RP; Witjes JA
    Curr Opin Urol; 2009 Sep; 19(5):511-5. PubMed ID: 19553821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
    Flamm J; Kühnel W; Dona S
    Urologe A; 1989 Mar; 28(2):99-102. PubMed ID: 2655259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer.
    Barocas DA; Liu A; Burks FN; Suh RS; Schuster TG; Bradford T; Moylan DA; Knapp PM; Murtagh DS; Morris D; Dunn RL; Montie JE; Miller DC
    J Urol; 2013 Dec; 190(6):2011-6. PubMed ID: 23792129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Willem Oosterlinck,Richard Sylvester, Marco Babjuk, et al. Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors? Eur Urol 2011;59:374-6.
    Gudjónsson S
    Eur Urol; 2011 Jul; 60(1):e2-3; author reply e4. PubMed ID: 21531071
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009;56;43-5.
    Gudjónsson S; Månsson W; Holmäng S; Liedberg F
    Eur Urol; 2010 Mar; 57(3):e28-9; author reply e30. PubMed ID: 19931978
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of non-muscle infiltrating tumours of the bladder].
    Irani J
    Prog Urol; 2009 Apr; 19(4):248-53. PubMed ID: 19329037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.